Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,408,894 | 1,637,520 | 1,527,720 | 1,362,931 | 1,834,534 |
| Marketable Securities | 178,547 | 286,810 | 354,010 | 68,620 | 285,575 |
| Receivables | 2,703,086 | 2,687,351 | 2,578,159 | 2,767,271 | 2,277,746 |
| Inventories | 1,862,294 | 1,784,713 | 1,941,785 | 1,952,115 | 1,323,926 |
| Other current assets | 162,316 | 145,028 | 177,004 | 176,282 | 62,826 |
| TOTAL | $6,315,136 | $6,541,421 | $6,578,678 | $6,327,219 | $5,784,607 |
| Non-Current Assets | |||||
| PPE Net | 2,296,216 | 2,158,106 | 2,073,485 | 2,129,580 | 1,851,668 |
| Investments And Advances | 0 | 0 | 0 | 210,592 | 0 |
| Intangibles | 4,381,423 | 4,416,866 | 4,290,259 | 4,365,639 | 4,059,734 |
| Other Non-Current Assets | 2,426,068 | 2,639,730 | 2,588,695 | 3,386,029 | 3,356,077 |
| TOTAL | $9,103,707 | $9,214,702 | $8,952,439 | $10,091,840 | $9,267,479 |
| Total Assets | $15,418,840 | $15,756,120 | $15,531,120 | $16,419,060 | $15,052,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,964,954 | 3,174,386 | 2,951,134 | 3,487,779 | 2,947,134 |
| Other current liabilities | 187,203 | 405,863 | 423,547 | 176,282 | 450,066 |
| TOTAL | $5,118,333 | $6,175,604 | $6,053,986 | $5,760,514 | $3,533,134 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,972,389 | 3,425,479 | 3,510,595 | 2,359,101 | 3,165,313 |
| Other Non-Current Liabilities | -54,105 | -44,373 | -27,394 | 918,086 | -46,834 |
| TOTAL | $5,089,116 | $4,660,384 | $4,685,359 | $3,990,596 | $4,722,268 |
| Total Liabilities | $10,207,450 | $10,835,990 | $10,739,350 | $9,751,110 | $8,255,402 |
| Shareholders' Equity | |||||
| Common Shares | 91,979 | 91,996 | 91,663 | 107,662 | 108,519 |
| Other shareholders' equity | 5,119,416 | 4,828,141 | 4,700,110 | 6,560,290 | 6,688,167 |
| TOTAL | $5,211,394 | $4,920,136 | $4,791,773 | $6,667,952 | $6,796,685 |
| Total Liabilities And Equity | $15,418,844 | $15,756,126 | $15,531,123 | $16,419,062 | $15,052,087 |